Your browser doesn't support javascript.
loading
Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.
Raizes, Elliot; Hader, Shannon; Birx, Deborah.
Afiliação
  • Raizes E; Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention.
  • Hader S; Division of Global HIV and Tuberculosis, Centers for Disease Control and Prevention.
  • Birx D; Office of the US Global AIDS Coordinator, US Department of State.
J Infect Dis ; 216(suppl_9): S805-S807, 2017 12 01.
Article em En | MEDLINE | ID: mdl-29206999
The US President's Emergency Plan for AIDS Relief (PEPFAR) supports aggressive scale-up of antiretroviral therapy (ART) in high-burden countries and across all genders and populations at risk toward global human immunodeficiency virus (HIV) epidemic control. PEPFAR recognizes the risk of HIV drug resistance (HIVDR) as a consequence of aggressive ART scale-up and is actively promoting 3 key steps to mitigate the impact of HIVDR: (1) routine access to routine viral load monitoring in all settings; (2) optimization of ART regimens; and (3) routine collection and analysis of HIVDR data to monitor the success of mitigation strategies. The transition to dolutegravir-based regimens in PEPFAR-supported countries and the continuous evolution of HIVDR surveillance strategies are essential elements of PEPFAR implementation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Carga Viral Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Carga Viral Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article